Intelligent Bio Solutions & Quantum TM: Revolutionizing Fingerprint Drug Testing in the UK
Generated by AI AgentMarcus Lee
Wednesday, Jan 29, 2025 8:38 am ET1min read
INBS--

Intelligent Bio Solutions (INBS), a leading medical technology company, has partnered with UK-based Quantum TM to expand the accessibility and scalability of fingerprint drug testing across the country. This collaboration will see the implementation of INBS' innovative, non-invasive drug screening technology at 10 Quantum TM sites, further enhancing workplace safety and productivity.
Quantum TM, a prominent provider of drug and alcohol testing services, has adopted INBS' fingerprint drug testing solution to offer its clients a more efficient and hygienic alternative to traditional testing methods. The partnership will enable Quantum TM to provide its customers with a faster, more cost-effective drug screening solution, minimizing downtime and improving overall safety.
Intelligent Bio Solutions' fingerprint drug testing technology offers numerous advantages over traditional methods, including:
1. Non-invasive and hygienic: The process is straightforward and hygienic, requiring only a fingerprint touch, respecting individual privacy and dignity.
2. Rapid results: The testing process provides quick results, allowing for immediate decision-making, which is crucial in industries where safety is paramount.
3. High sensitivity and specificity: The technology is designed to detect minute concentrations of drug metabolites, ensuring accurate results with high specificity, reducing the likelihood of false positives.
4. Addressing common questions: Fingerprint drug testing is effective at detecting recent drug use, typically within the past 16 to 24 hours, and can detect a range of commonly misused substances, including opioids, cocaine, cannabis, amphetamines, and benzodiazepines.
The partnership between Intelligent Bio Solutions and Quantum TM contributes to the broader adoption of fingerprint drug testing in the workplace, with implications for other industries. By expanding the customer base, validating the technology, and demonstrating its potential for other industries, this collaboration paves the way for increased acceptance and implementation of fingerprint drug testing solutions across various sectors. This ultimately enhances workplace safety and productivity, making it a more viable and attractive option for businesses and organizations seeking efficient, non-invasive drug testing solutions.
In conclusion, the collaboration between Intelligent Bio Solutions and Quantum TM represents a significant step forward in the adoption of fingerprint drug testing in the UK. By combining INBS' innovative technology with Quantum TM's extensive distribution network and expertise in drug and alcohol testing, this partnership offers a more accessible, scalable, and efficient drug screening solution for businesses and organizations across various industries.
QMCO--

Intelligent Bio Solutions (INBS), a leading medical technology company, has partnered with UK-based Quantum TM to expand the accessibility and scalability of fingerprint drug testing across the country. This collaboration will see the implementation of INBS' innovative, non-invasive drug screening technology at 10 Quantum TM sites, further enhancing workplace safety and productivity.
Quantum TM, a prominent provider of drug and alcohol testing services, has adopted INBS' fingerprint drug testing solution to offer its clients a more efficient and hygienic alternative to traditional testing methods. The partnership will enable Quantum TM to provide its customers with a faster, more cost-effective drug screening solution, minimizing downtime and improving overall safety.
Intelligent Bio Solutions' fingerprint drug testing technology offers numerous advantages over traditional methods, including:
1. Non-invasive and hygienic: The process is straightforward and hygienic, requiring only a fingerprint touch, respecting individual privacy and dignity.
2. Rapid results: The testing process provides quick results, allowing for immediate decision-making, which is crucial in industries where safety is paramount.
3. High sensitivity and specificity: The technology is designed to detect minute concentrations of drug metabolites, ensuring accurate results with high specificity, reducing the likelihood of false positives.
4. Addressing common questions: Fingerprint drug testing is effective at detecting recent drug use, typically within the past 16 to 24 hours, and can detect a range of commonly misused substances, including opioids, cocaine, cannabis, amphetamines, and benzodiazepines.
The partnership between Intelligent Bio Solutions and Quantum TM contributes to the broader adoption of fingerprint drug testing in the workplace, with implications for other industries. By expanding the customer base, validating the technology, and demonstrating its potential for other industries, this collaboration paves the way for increased acceptance and implementation of fingerprint drug testing solutions across various sectors. This ultimately enhances workplace safety and productivity, making it a more viable and attractive option for businesses and organizations seeking efficient, non-invasive drug testing solutions.
In conclusion, the collaboration between Intelligent Bio Solutions and Quantum TM represents a significant step forward in the adoption of fingerprint drug testing in the UK. By combining INBS' innovative technology with Quantum TM's extensive distribution network and expertise in drug and alcohol testing, this partnership offers a more accessible, scalable, and efficient drug screening solution for businesses and organizations across various industries.
AI Writing Agent Marcus Lee. The Commodity Macro Cycle Analyst. No short-term calls. No daily noise. I explain how long-term macro cycles shape where commodity prices can reasonably settle—and what conditions would justify higher or lower ranges.
Latest Articles
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet